Barclays PLC Acquires 62,042 Shares of Core Laboratories Inc. (NYSE:CLB)

Barclays PLC raised its position in Core Laboratories Inc. (NYSE:CLB - Free Report) by 288.2% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 83,570 shares of the oil and gas company's stock after purchasing an additional 62,042 shares during the quarter. Barclays PLC owned 0.18% of Core Laboratories worth $1,549,000 as of its most recent SEC filing.

Several other large investors have also recently bought and sold shares of CLB. State Street Corp lifted its holdings in shares of Core Laboratories by 2.9% during the third quarter. State Street Corp now owns 1,975,016 shares of the oil and gas company's stock worth $36,597,000 after purchasing an additional 56,187 shares during the period. Disciplined Growth Investors Inc. MN raised its position in Core Laboratories by 446.8% during the 2nd quarter. Disciplined Growth Investors Inc. MN now owns 4,460,720 shares of the oil and gas company's stock worth $90,508,000 after purchasing an additional 3,644,963 shares during the last quarter. Envestnet Asset Management Inc. raised its position in Core Laboratories by 12.5% during the 2nd quarter. Envestnet Asset Management Inc. now owns 306,287 shares of the oil and gas company's stock worth $6,215,000 after purchasing an additional 34,149 shares during the last quarter. Earnest Partners LLC grew its position in shares of Core Laboratories by 6.3% in the 2nd quarter. Earnest Partners LLC now owns 3,286,438 shares of the oil and gas company's stock valued at $66,682,000 after buying an additional 195,756 shares during the last quarter. Finally, Headlands Technologies LLC bought a new stake in shares of Core Laboratories in the 2nd quarter valued at about $36,000. 97.81% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

A number of equities analysts have recently issued reports on CLB shares. Citigroup lowered their price objective on Core Laboratories from $15.00 to $14.00 and set a "sell" rating for the company in a research report on Thursday, October 31st. StockNews.com upgraded shares of Core Laboratories from a "sell" rating to a "hold" rating in a report on Thursday, November 7th. Two equities research analysts have rated the stock with a sell rating and three have issued a hold rating to the company's stock. According to data from MarketBeat, the stock has a consensus rating of "Hold" and an average price target of $17.00.

Core Laboratories Trading Down 1.9 %

Shares of NYSE:CLB traded down $0.33 during midday trading on Friday, reaching $16.74. The company's stock had a trading volume of 274,161 shares, compared to its average volume of 410,595. The firm has a 50 day moving average price of $19.41 and a two-hundred day moving average price of $19.63. Core Laboratories Inc. has a fifty-two week low of $13.82 and a fifty-two week high of $25.13. The firm has a market capitalization of $785.94 million, a price-to-earnings ratio of 25.75, a PEG ratio of 1.36 and a beta of 2.35. The company has a debt-to-equity ratio of 0.55, a quick ratio of 1.79 and a current ratio of 2.48.

Core Laboratories (NYSE:CLB - Get Free Report) last issued its quarterly earnings results on Wednesday, October 23rd. The oil and gas company reported $0.25 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.21 by $0.04. The firm had revenue of $134.40 million for the quarter, compared to analyst estimates of $134.16 million. Core Laboratories had a return on equity of 15.84% and a net margin of 5.83%. The company's revenue was up 7.2% compared to the same quarter last year. During the same period in the previous year, the firm earned $0.22 earnings per share. As a group, analysts forecast that Core Laboratories Inc. will post 0.8 earnings per share for the current year.

Core Laboratories Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Monday, November 25th. Shareholders of record on Monday, November 4th were paid a $0.01 dividend. This represents a $0.04 annualized dividend and a yield of 0.24%. The ex-dividend date was Monday, November 4th. Core Laboratories's dividend payout ratio (DPR) is currently 6.15%.

Core Laboratories Profile

Core Laboratories Inc provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and gas from its clients' reservoirs.